Quarter Period Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7543334

Concept 2023-03-01 to
2023-08-31
2022-03-01 to
2022-08-31
Quarter period statement of income
Statement of income
Net sales
66,977,000,000 JPY
59,619,000,000 JPY
Cost of sales
28,330,000,000 JPY
25,156,000,000 JPY
Gross profit (loss)
38,646,000,000 JPY
34,462,000,000 JPY
Selling, general and administrative expenses
30,250,000,000 JPY
29,549,000,000 JPY
Selling, general and administrative expenses
Advertising expenses
6,823,000,000 JPY
5,573,000,000 JPY
Operating profit (loss)
8,396,000,000 JPY
4,913,000,000 JPY
Non-operating income
Interest income
1,128,000,000 JPY
202,000,000 JPY
Dividend income
567,000,000 JPY
501,000,000 JPY
Non-operating income
3,336,000,000 JPY
4,074,000,000 JPY
Non-operating expenses
Interest expenses
7,000,000 JPY
4,000,000 JPY
Non-operating expenses
91,000,000 JPY
118,000,000 JPY
Ordinary profit (loss)
11,640,000,000 JPY
8,870,000,000 JPY
Extraordinary income
Extraordinary income
JPY
142,000,000 JPY
Extraordinary losses
Extraordinary losses
2,000,000 JPY
77,000,000 JPY
Profit (loss) before income taxes
11,638,000,000 JPY
8,935,000,000 JPY
Income taxes
2,967,000,000 JPY
2,215,000,000 JPY
Profit (loss)
8,671,000,000 JPY
6,720,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.